25 January 2022
Barkby Group PLC
("Barkby" or the "Company")
Cambridge Sleep Sciences Announces New Partners
Sleep technology business announces multiple new partners as growth continues
Barkby Group PLC (AIM:BARK) is pleased to announce that its subsidiary, Cambridge Sleep Sciences ("CSS"), the science-based sleep technology business behind SleepHub®, has developed more than 10 new sales partnerships as part of its continued growth strategy.
The partnerships, all with leading international businesses, includes retailers Harrods, Smartech (in Selfridges), Currys and Very; sales agents and distributors TKG, Go10, NewGen and Sleep Analysis Australia; and health, wellbeing and fitness brands Lifeworks, Whitecalm and PureGym. CSS's new partnerships will enable them to capitalise on the growing global sleep tech devices market which is forecast to grow at a CAGR of nearly 11% and exceed $30bn by 2028.*
These partnerships follow the recent shortlisting of CSS as a finalist in the innovation category of the Medilink Midlands Business Awards for their SleepHub® Home product. CSS also recently announced the development of a portable product - SleepHub® Anywhere, due to be launched this year in Spring.
CSS is progressing a number of further major partnerships and looks forward to announcing these shortly.
Dr Julian Stone, CEO of CSS, said: "I'm delighted to be partnering with these leading household names as we continue to extend the reach of SleepHub® in our key markets. Collaboration has always been at the heart of our business and we are looking forward to a successful year working with all of our partners to play a role in addressing the global sleep challenge."
* Data Bridge Market Research: Global Sleep Tech Devices Market - Industry Trends and Forecast to 2028
ENDS
Enquiries:
| Barkby Group plc Charles Dickson (Executive Chairman) Douglas Benzie (CFO)
| via Camarco | | |
| finnCap Ltd (Nomad and Broker) Carl Holmes/Simon Hicks (corporate finance) Tim Redfern/Richard Chambers (ECM)
| +44 (0) 20 7220 0500 | ||
| Camarco (Financial PR) Jennifer Renwick/Jake Thomas | +44 (0) 20 3757 4994 | ||
| | | | |
Notes to editors
About Cambridge Sleep Sciences
CSS, part of The Barkby Group Plc, create sleep products which use patented scientifically formulated sound technology to help users achieve quality, natural sleep. Their first product, SleepHub® Home, delivers the unique 'sleep sounds' using a pair of premium speakers. The forthcoming Anywhere product uses the same technology in a compact, portable device, controlled by a mobile app with the sounds delivered through a choice of Bluetooth devices. Other applications of the technology, such as licensing, are in advanced stages and development of their innovation pipeline will remain a focus during this year and beyond.
About Barkby Group
Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include: Barkby Real Estate, Barkby Pub Co. and Barkby Investments (comprising of Workshop Coffee, Centurian Automotive, Cambridge Sleep Sciences and a minority stake in Verso Biosense).
Barkby's strategy is to accelerate and maximise opportunities within its existing businesses.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.